Obesity is recognized as a chronic disease that can increase the risk of diabetes, heart disease, stroke, and other serious health conditions
Dietary modification is crucial for managing hunger on Saxenda
Food and Drug Administration continue to monitor post-marketing safety signals
doi: 10.1053/j.gastro.2007.03.054 [DOI] [PubMed] [Google Scholar] 13
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice
A meta-analysis [74] including the ELIXA [66], LEADER [44], SUSTAIN-6 [67], EXSCEL [68], REWIND [70], and AMPLITUDE-O [51] studies found that GLP-1RAs were associated with better renal outcomes: a 30% or 40% or more decrease in glomerular filtration rate, need for renal replacement therapy, end-stage renal failure, or death from kidney disease by 21%